Colgate-Palmolive EVP reports small tax-related share withholding

Colgate-Palmolive Company executive Kristine Hutchinson, EVP and Controller, reported a small tax-related stock transaction.

Rhea-AI Filing Summary

Colgate-Palmolive Company executive Kristine Hutchinson, EVP and Controller, reported a small tax-related stock transaction. On 12/03/2025, 41 shares of Colgate-Palmolive common stock were disposed of at $78.2 per share under transaction code "F," which indicates shares were withheld to cover taxes on previously granted restricted stock units.

After this transaction, Hutchinson beneficially owns 11,879 shares of Colgate-Palmolive common stock directly and 8,497 shares indirectly through the issuer's 401(k) plan trustee. The explanation notes that she continues to hold the original restricted stock units, reduced only by the number of shares withheld to satisfy Medicare and income tax obligations.

Insider Trade Summary

Exercise Price or Tax Liability: 41 shares

Exercise Price or Tax Liability 2 txns

Insider Malcolm Gregory

Role EVP and Controller

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	41	$78.20	$3K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 11,879 shares (Direct); Common Stock — 8,497 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (1)

1. F1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Colgate-Palmolive (CL) report for Kristine Hutchinson?

The filing reports that EVP and Controller Kristine Hutchinson had 41 shares of Colgate-Palmolive common stock disposed of on 12/03/2025 in a tax-related transaction coded "F."

Why were Colgate-Palmolive (CL) shares withheld from Kristine Hutchinson?

The shares were withheld to pay Medicare and income tax liability arising from restricted stock units previously granted under Colgate-Palmolive's incentive compensation plan.

How many Colgate-Palmolive (CL) shares does Kristine Hutchinson own after the transaction?

After the transaction, Kristine Hutchinson beneficially owns 11,879 shares of Colgate-Palmolive common stock directly and 8,497 shares indirectly through the issuer's 401(k) plan trustee.

Does the tax withholding transaction affect Kristine Hutchinson's restricted stock units in Colgate-Palmolive (CL)?

The filing states that Hutchinson continues to hold the restricted stock units originally granted, reduced only by the amount of shares withheld to satisfy required tax withholding.

What is transaction code "F" in Kristine Hutchinson's Colgate-Palmolive (CL) Form 4?

Transaction code "F" identifies a transaction where shares are used to pay tax obligations, in this case withholding shares from restricted stock units to cover Medicare and income taxes.

What is Kristine Hutchinson’s role at Colgate-Palmolive (CL)?

Kristine Hutchinson is an officer of Colgate-Palmolive, serving as Executive Vice President (EVP) and Controller, as indicated in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/05/2025 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malcolm Gregory

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Controller

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		F(1)		41	D	$78.2	11,879	D
Common Stock								8,497	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

	/s/ Kristine Hutchinson, Attorney-in-Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.